Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B

Infection with hepatitis B virus (HBV) is responsible for the increasing global hepatitis burden, with an estimated 296 million people being carriers and living with the risk of developing chronic liver disease and cancer. While the current treatment options for chronic hepatitis B (CHB), including...

Descripción completa

Detalles Bibliográficos
Autores principales: Suresh, Manasa, Menne, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416195/
https://www.ncbi.nlm.nih.gov/pubmed/36016334
http://dx.doi.org/10.3390/v14081711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416195/
https://www.ncbi.nlm.nih.gov/pubmed/36016334
http://dx.doi.org/10.3390/v14081711

Ejemplares similares